Beneficial or harmful effect of antipaternal human leukocyte antibodies on pregnancy outcome? A systematic review and meta-analysis

American Journal of Reproductive Immunology

Volumn 70, Issue 2, 2013, Pages 87-103

  Lashley, Eileen E L O ^a   Meuleman, Tess ^a   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antipaternal antibodies; Human leukocyte antigen antibodies; Preeclampsia; Pregnancy complication; Preterm labor; Recurrent miscarriage

Indexed keywords

HLA ANTIBODY; IMMUNOGLOBULIN; LEUKOCYTE ANTIBODY; PATERNAL LEUKOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; CELL MIGRATION; CHORIOAMNIONITIS; COMPLEMENT DEPENDENT CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ETHNICITY; FIRST TRIMESTER PREGNANCY; FLOW CYTOMETRY; GESTATIONAL AGE; HISPANIC; HUMAN; IMMUNOFLUORESCENCE; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE; META ANALYSIS; MICROCHIMERISM; PREECLAMPSIA; PREGNANCY COMPLICATION; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SEXUAL INTERCOURSE; SOLUTIO PLACENTAE; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; THIRD TRIMESTER PREGNANCY;

ANTIPATERNAL ANTIBODIES; HUMAN LEUKOCYTE ANTIGEN ANTIBODIES; PREECLAMPSIA; PREGNANCY COMPLICATION; PRETERM LABOR; RECURRENT MISCARRIAGE;

ANTIBODIES; FATHERS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA ANTIGENS; HUMANS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 84880305013     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12109     Document Type: Review

References (61)

1. Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW: Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 2007; 178:5949-5956.
2. Sargent IL, Borzychowski AM, Redman CW: NK cells and human pregnancy - an inflammatory view. Trends Immunol 2006; 27:399-404.
3. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, Lee TH: Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001; 41:1524-1530.
4. Bouma GJ, van CP, van Bree SP, Castelli-Visser RM, Witvliet MD, van der Meer-Prins EM, van Rood JJ, Claas FH: Pregnancy can induce priming of cytotoxic T lymphocytes specific for paternal HLA antigens that is associated with antibody formation. Transplantation 1996; 62:672-678.
5. van Kampen CA, Versteeg-vd Voort Maarschalk MF, Langerak-Langerak J, Roelen DL, Claas FH: Kinetics of the pregnancy-induced humoral and cellular immune response against the paternal HLA class I antigens of the child. Hum Immunol 2002; 63:452-458.
6. Verdijk RM, Kloosterman A, Pool J, van der Keur C, Naipal AM, van Halteren AG, Brand A, Mutis T, Goulmy E: Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood 2004; 103:1961-1964.
7. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, Kanhai HH, Claas FH, Scherjon SA: Differential distribution of CD4(+)CD25(bright) and CD8(+)CD28(-) T-cells in decidua and maternal blood during human pregnancy. Placenta 2006; 27(Suppl. A):S47-S53.
8. Parham P: The immune system, 3rd edn. New York, Garland Science, Taylor & Francis Group, 2009.
9. van Rood JJ, Eernisse JG, van Leeuwen A: Leucocyte antibodies in sera from pregnant women. Nature 1958; 181:1735-1736.
10. Payne R, Rolfs MR: Fetomaternal leukocyte incompatibility. J Clin Invest 1958; 37:1756-1763.
11. van Kampen CA, Versteeg-van der Voort Maarschalk MF, Langerak-Langerak J, van BE, Roelen DL, Claas FH: Pregnancy can induce long-persisting primed CTLs specific for inherited paternal HLA antigens. Hum Immunol 2001; 62:201-207.
12. Regan L, Braude PR, Hill DP: A prospective study of the incidence, time of appearance and significance of anti-paternal lymphocytotoxic antibodies in human pregnancy. Hum Reprod 1991; 6:294-298.
13. Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, Glynn SA, Hillyer CD, Carey P, Gottschall JL, Murphy EL, Rios JA, Ness PM, Wright DJ, Carrick D, Schreiber GB: The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49:1825-1835.
14. Dankers MK, Roelen DL, Korfage N, de LP, Witvliet M, Sandkuijl L, Doxiadis II, Claas FH: Differential immunogenicity of paternal HLA Class I antigens in pregnant women. Hum Immunol 2003; 64:600-606.
15. Duquesnoy RJ: The antibody response to an HLA mismatch: a model for nonself-self discrimination in relation to HLA epitope immunogenicity. Int J Immunogenet 2012; 39:1-9.
16. Dankers MK, Witvliet MD, Roelen DL, de LP, Korfage N, Persijn GG, Duquesnoy R, Doxiadis II, Claas FH: The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens. Transplantation 2004; 77:1236-1239.
17. van Kampen CA, Versteeg-van der Voort Maarschalk MF, Roelen DL, Claas FH: Primed CTLs specific for HLA class I may still be present in sensitized patients when anti-HLA antibodies have disappeared: relevance for donor selection. Transplantation 2002; 73:1286-1290.
18. Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schonemann C: Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts. Transplantation 2009; 87:1505-1513.
19. The Trial to Reduce Alloimmunization to Platelets Study Group: Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997; 337:1861-1869.
20. Middelburg RA, van SD, Briet E, van der Bom JG: The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008; 48:2167-2176.
21. Buurma A, Cohen D, Veraar K, Schonkeren D, Claas FH, Bruijn JA, Bloemenkamp KW, Baelde HJ: Preeclampsia is characterized by placental complement dysregulation. Hypertension 2012; 60:1332-1337.
22. Steinborn A, Seidl C, Sayehli C, Sohn C, Seifried E, Kaufmann M, Schmitt E: Anti-fetal immune response mechanisms may be involved in the pathogenesis of placental abruption. Clin Immunol 2004; 110:45-54.
23. Lee J, Romero R, Xu Y, Kim JS, Park JY, Kusanovic JP, Chaiworapongsa T, Hassan SS, Kim CJ: Maternal HLA panel-reactive antibodies in early gestation positively correlate with chronic chorioamnionitis: evidence in support of the chronic nature of maternal anti-fetal rejection. Am J Reprod Immunol 2011; 66:510-526.
24. Lee J, Romero R, Xu Y, Kim JS, Topping V, Yoo W, Kusanovic JP, Chaiworapongsa T, Hassan SS, Yoon BH, Kim CJ: A signature of maternal anti-fetal rejection in spontaneous preterm birth: chronic chorioamnionitis, anti-human leukocyte antigen antibodies, and C4d. PLoS ONE 2011; 6:e16806.
25. Nielsen HS, Witvliet MD, Steffensen R, Haasnoot GW, Goulmy E, Christiansen OB, Claas F: The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol 2010; 87:67-73.
26. Bartel G, Walch K, Wahrmann M, Pils S, Kussel L, Polterauer S, Tempfer C, Bohmig GA: Prevalence and qualitative properties of circulating anti-human leukocyte antigen alloantibodies after pregnancy: no association with unexplained recurrent miscarriage. Hum Immunol 2011; 72:187-192.
27. Steinborn A, Saran G, Schneider A, Fersis N, Sohn C, Schmitt E: The presence of gestational diabetes is associated with increased detection of anti-HLA-class II antibodies in the maternal circulation. Am J Reprod Immunol 2006; 56:124-134.
28. Kishore R, Agarwal S, Halder A, Das V, Shukla BR, Agarwal SS: HLA sharing, anti-paternal cytotoxic antibodies and MLR blocking factors in women with recurrent spontaneous abortion. J Obstet Gynaecol Res 1996; 22:177-183.
29. Fujisawa S: HLA antigens-antibodies system and its association with severe toxemia of pregnancy. Nihon Sanka Fujinka Gakkai Zasshi 1985; 37:124-130.
30. Jenkins DM, Need J, Kajah SM: Deficienty of specific HLA antibodies in severe pregnancy pre-eclampsia/eclampsia. Clin Exp Immunol 1977; 27:485-486.
31. Bolis PF, Martinetti BM, La FA, Franchi M, Cuccia BM: Immunogenetic aspects of preeclampsia. Biol Res Pregnancy Perinatol 1987; 8:42-45.
32. Coulam CB: Immunologic tests in the evaluation of reproductive disorders: a critical review. Am J Obstet Gynecol 1992; 167:1844-1851.
33. Biddle PK, Friedman CI, Johnson PM: Lymphocyte-reactive antibodies and recurrent early pregnancy failure. Am J Obstet Gynecol 1987; 157:785-786.
34. Agrawal S, Pandey MK, Mandal S, Mishra L, Agarwal S: Humoral immune response to an allogenic foetus in normal fertile women and recurrent aborters. BMC Pregnancy Childbirth 2002; 2:6.
35. Sargent IL, Wilkins T, Redman CW: Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage. Lancet 1988; 2:1099-1104.
36. Umapathy S, Shankarkumar A, Ramrakhiyani V, Ghosh K: Role of anti-human lymphocyte culture cytotoxic antibodies in recurrent spontaneous pregnancy loss women. J Hum Reprod Sci 2011; 4:17-19.
37. Shankarkumar U, Pradhan VD, Patwardhan MM, Shankarkumar A, Ghosh K: Autoantibody profile and other immunological parameters in recurrent spontaneous abortion patients. Niger Med J 2011; 52:163-166.
38. Souza SS, Ferriani RA, Santos CM, Voltarelli JC: Immunological evaluation of patients with recurrent abortion. J Reprod Immunol 2002; 56:111-121.
39. Terasaki PI, Bernoco D, Park MS, Ozturk G, Iwaki Y: Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture. Am J Clin Pathol 1978; 69:103-120.
40. Zachary AA, Kopchaliiska D, Jackson AM, Leffell MS: Immunogenetics and immunology in transplantation. Immunol Res 2010; 47:232-239.
41. Adeyi OA, Girnita AL, Howe J, Marrari M, Awadalla Y, Askar M, Martell J, Zeevi A, Shapiro R, Nalesnik M, Randhawa P, Demetris AJ, Duquesnoy RJ: Serum analysis after transplant nephrectomy reveals restricted antibody specificity patterns against structurally defined HLA class I mismatches. Transpl Immunol 2005; 14:53-62.
42. Saftlas AF, Levine RJ, Klebanoff MA, Martz KL, Ewell MG, Morris CD, Sibai BM: Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am J Epidemiol 2003; 157:1108-1114.
43. Saftlas AF, Beydoun H, Triche E: Immunogenetic determinants of preeclampsia and related pregnancy disorders: a systematic review. Obstet Gynecol 2005; 106:162-172.
44. Robillard PY, Hulsey TC, Perianin J, Janky E, Miri EH, Papiernik E: Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994; 344:973-975.
45. Robertson SA, Guerin LR, Bromfield JJ, Branson KM, Ahlstrom AC, Care AS: Seminal fluid drives expansion of the CD4 + CD25 + T regulatory cell pool and induces tolerance to paternal alloantigens in mice. Biol Reprod 2009; 80:1036-1045.
46. Klonoff-Cohen HS, Savitz DA, Cefalo RC, McCann MF: An epidemiologic study of contraception and preeclampsia. JAMA 1989; 262:3143-3147.
47. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA: Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996; 93:705-708.
48. Bianchi DW, Farina A, Weber W, Delli-Bovi LC, Deriso M, Williams JM, Klinger KW: Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 2001; 184:703-706.
49. Khosrotehrani K, Johnson KL, Lau J, Dupuy A, Cha DH, Bianchi DW: The influence of fetal loss on the presence of fetal cell microchimerism: a systematic review. Arthritis Rheum 2003; 48:3237-3241.
50. Al-Mufti R, Hambley H, Albaiges G, Lees C, Nicolaides KH: Increased fetal erythroblasts in women who subsequently develop pre-eclampsia. Hum Reprod 2000; 15:1624-1628.
51. Holzgreve W, Ghezzi F, Di NE, Ganshirt D, Maymon E, Hahn S: Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998; 91:669-672.
52. Al-Mufti R, Lees C, Albaiges G, Hambley H, Nicolaides KH: Fetal cells in maternal blood of pregnancies with severe fetal growth restriction. Hum Reprod 2000; 15:218-221.
53. Simchen MJ, Barkai G, Lusky A, Guetta E: Fetal hemoglobin-expressing nucleated red blood cell frequencies in pregnancies with intrauterine growth restriction. Prenat Diagn 2001; 21:31-35.
54. Roelen DL, Doxiadis II, Claas FH: Detection and clinical relevance of donor specific HLA antibodies: a matter of debate. Transpl Int 2012; 25:604-610.
55. Ting A, Morris PJ: Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies. Tissue Antigens 1983; 21:219-226.
56. Lee J, Romero R, Dong Z, Xu Y, Qureshi F, Jacques S, Yoo W, Chaiworapongsa T, Mittal P, Hassan SS, Kim CJ: Unexplained fetal death has a biological signature of maternal anti-fetal rejection: chronic chorioamnionitis and alloimmune anti-human leucocyte antigen antibodies. Histopathology 2011; 59:928-938.
57. Zoet YM, Brand-Schaaf SH, Roelen DL, Mulder A, Claas FH, Doxiadis II: Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations? Tissue Antigens 2011; 77:225-228.
58. Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberu J: "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86:1111-1115.
59. Zoet YM, Eijsink C, Bohmova R, Witvliet MD, Kardol MJ, Franke ME, Claas FH, Mulder A, Doxiadis II: Single-antigen-expressing cell lines are excellent tools for detecting human leukocyte antigen-C-reactive antibodies in kidney transplant recipients. Transplantation 2005; 79:1268-1272.
60. King KE, Kao KJ, Bray PF, Casella JF, Blakemore K, Callan NA, Kennedy SD, Kickler TS: The role of HLA antibodies in neonatal thrombocytopenia: a prospective study. Tissue Antigens 1996; 47:206-211.
61. Tanaka T, Umesaki N, Nishio J, Maeda K, Kawamura T, Araki N, Ogita S: Neonatal thrombocytopenia induced by maternal anti-HLA antibodies: a potential side effect of allogenic leukocyte immunization for unexplained recurrent aborters. J Reprod Immunol 2000; 46:51-57.